Company intelligence / Profile preview
Norwich Pharmacal Company
- Ownership
- Private
- Development stage
- Other
Overview
Norwich Pharmacal Company was a significant American pharmaceutical firm founded in 1885 and headquartered in Norwich, New York. The company gained prominence for developing and marketing iconic consumer brands such as Pepto-Bismol and Unguentine, as well as pioneering research in nitrofuran chemistry which led to the antibacterial drug Furadantin. In 1969, it merged with Morton International to form Morton-Norwich Products, and its pharmaceutical division, Norwich-Eaton, was later acquired by Procter & Gamble in 1982. The company's legacy is defined by its transition from a small local pill manufacturer to a major contributor to both over-the-counter and prescription medicine markets.
- Therapeutic areas
- NeurologyDermatologyInfectious DiseasesRare DiseasesGastroenterology
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Norwich Pharmacal Company.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Norwich Pharmacal Company.